Vault-13

Ponoi Management, LLC

San Francisco, CA · CIK 1720702 · 13F filing filed 2021-08-16

No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.

$180.0m reported value +5.9% vs Q1 2021
5positions
100.0%in top 10
0 new 0 added 0 reduced 0 sold out vs Q1 2021

Holdings, Q2 2021

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 CONSTELLATION PHARMCETICLS I COM CNST CNST 1,880,623 $63.6m35.32% 35.32% UnchangedShares held: Q3 2020 0, Q4 2020 1.9m, Q1 2021 1.9m, Q2 2021 1.9m
2 RAPT THERAPEUTICS INC COM COM 1,599,417 $50.8m28.25% 28.25% UnchangedShares held: Q3 2020 0, Q4 2020 1.6m, Q1 2021 1.6m, Q2 2021 1.6m
3 NGM BIOPHARMACEUTICALS INC COM NGM NGM 1,298,908 $25.6m14.23% 14.23% UnchangedShares held: Q3 2020 0, Q4 2020 1.3m, Q1 2021 1.3m, Q2 2021 1.3m
4 REVOLUTION MEDICINES INC COM RVMD RVMD 685,011 $21.7m12.08% 12.08% UnchangedShares held: Q3 2020 0, Q4 2020 685.0k, Q1 2021 685.0k, Q2 2021 685.0k
5 NURIX THERAPEUTICS INC COM NRIX NRIX 686,274 $18.2m10.12% 10.12% UnchangedShares held: Q3 2020 0, Q4 2020 686.3k, Q1 2021 686.3k, Q2 2021 686.3k